Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Cid

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
Blood|May 24, 2017
SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphomaPatricia Balsas, Jara Palomero, Álvaro Eguileor, et al.
Autoimmunity Reviews|February 1, 2017
Characterization of isolated retinal vasculitis. Analysis of a cohort from a single center and literature reviewLaura Pelegrín, José Hernández-Rodríguez, Gerard Espinosa, et al.
Circulation|September 25, 2002
Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritisMaria C Cid, José Hernández-Rodríguez, María-José Esteban, et al.
Medicine|August 27, 2013
Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 PatientsSoledad Retamozo, Cándido Díaz-Lagares, Xavier Bosch, et al.
Frontiers in Endocrinology|July 28, 2025
Risk factors for glucocorticoid induced osteoporosis in young adultsHelena Florez, Josep Lluis Carrasco, Martina Barberá, et al.
Seminars in Arthritis and Rheumatism|December 10, 2013
Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritisMarco A Alba, Ana García-Martínez, Sergio Prieto-González, et al.
Rheumatology (Oxford, England)|August 30, 2011
Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal studySudha Visvanathan, Mahboob U Rahman, Gary S Hoffman, et al.
Circulation Research|June 13, 2020
B55α/PP2A Limits Endothelial Cell Apoptosis During Vascular Remodeling: A Complementary Approach To Disrupt Pathological Vessels?Manuel Ehling, Ward Celus, Rosa Martín-Pérez, et al.
The Lancet. Rheumatology|January 27, 2024
Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trialJohn H Stone, Jian Han, Martin Aringer, et al.
Arthritis and Rheumatism|March 4, 2008
Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patientsAna García-Martínez, José Hernández-Rodríguez, Pedro Arguis, et al.
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
Blood|May 24, 2017
SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphomaPatricia Balsas, Jara Palomero, Álvaro Eguileor, et al.
Autoimmunity Reviews|February 1, 2017
Characterization of isolated retinal vasculitis. Analysis of a cohort from a single center and literature reviewLaura Pelegrín, José Hernández-Rodríguez, Gerard Espinosa, et al.
Circulation|September 25, 2002
Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritisMaria C Cid, José Hernández-Rodríguez, María-José Esteban, et al.
Medicine|August 27, 2013
Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 PatientsSoledad Retamozo, Cándido Díaz-Lagares, Xavier Bosch, et al.
Frontiers in Endocrinology|July 28, 2025
Risk factors for glucocorticoid induced osteoporosis in young adultsHelena Florez, Josep Lluis Carrasco, Martina Barberá, et al.
Seminars in Arthritis and Rheumatism|December 10, 2013
Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritisMarco A Alba, Ana García-Martínez, Sergio Prieto-González, et al.
Rheumatology (Oxford, England)|August 30, 2011
Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal studySudha Visvanathan, Mahboob U Rahman, Gary S Hoffman, et al.
Circulation Research|June 13, 2020
B55α/PP2A Limits Endothelial Cell Apoptosis During Vascular Remodeling: A Complementary Approach To Disrupt Pathological Vessels?Manuel Ehling, Ward Celus, Rosa Martín-Pérez, et al.
The Lancet. Rheumatology|January 27, 2024
Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trialJohn H Stone, Jian Han, Martin Aringer, et al.
Arthritis and Rheumatism|March 4, 2008
Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patientsAna García-Martínez, José Hernández-Rodríguez, Pedro Arguis, et al.
Pageof 15